Why West Africa rejected donation of Chinese medicine for treating Ebola recommended by Chinese government?

Complementary Therapies in Medicine

Volume 23, Issue 3, 1 June 2015, Pages 505-507

Zhang, Y.^a , 

Zhang, Y.^a , 

Guyatt, G.H.^b

 

^a  Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street, Hamilton, ON, Canada
^b  Department of Clinical Epidemiology, Biostatistics, and Medicine, McMaster University, Hamilton, ON, 

View additional affiliations

View references (15)

Abstract

[No abstract available]

Author keywords

Chinese Medicine; Ebola; Recommendations

Indexed keywords

EMTREE drug terms: Chinese drug; pien tze huang; unclassified drug; herbaceous agent; pien tze huang

EMTREE medical terms: acute kidney failure; Africa; antiinflammatory activity; antiviral activity; bioethics; brain damage; chemical composition; Chinese medicine; dengue; detoxification; drug control; drug efficacy; drug marketing; drug mechanism; drug safety; Ebola hemorrhagic fever; endangered species; esophagus cancer; evidence based medicine; government regulation; human; hyperpyrexia; Letter; liver cancer; liver cell carcinoma; medical decision making; meningoencephalitis; mumps; nonhuman; outcome assessment; pneumonia; practice guideline; randomized controlled trial (topic); risk benefit analysis; unspecified side effect; virus infection; West Africa; Africa; China; drug industry; Ebola hemorrhagic fever; international cooperation; refusal to participate

MeSH: Africa, Western; China; Drug Industry; Drugs, Chinese Herbal; Hemorrhagic Fever, Ebola; Humans; International Cooperation; Refusal to Participate
Medline is the source for the MeSH terms of this document.

Chemicals and CAS Registry Numbers: Drugs, Chinese Herbal; pien tze huang

Manufacturers:Drug manufacturer: Zhangzhou Pien Tze Huang Pharmaceutical.

ISSN: 09652299 CODEN: CTHMESource Type: Journal Original language: English

DOI: 10.1016/j.ctim.2015.03.012 PubMed ID: 26051586Document Type: Letter

Publisher: Churchill Livingstone

References (15)

View in search results format

• Page
 
• • Export |
  • Print |
  • E-mail |
  • Create bibliography

• 
  1

  (2014) Situation reports: Ebola response roadmap update. Cited 2 times.
  [accessed 18.10.14]
  http://apps.who.int/iris/bitstream/10665/136645/1/roadmapupdate17Oct14_eng.pdf?ua=1
  

  •  
• 
  2

  (2014) Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD). Cited 23 times.
  [accessed 18.10.14]
  http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/
  

  •  
• 
  3

  Huiling, F.
  (2014) Pien Tze Huang refused to be donated to the West African Ebola unable to determine the clinical efficacy of treatment
  [accessed 18.10.14]
  http://sz.learnatchina.com/201410157872-pien-tze-huang-refused-to-be-donated-to-the-west-african-ebola-unable-to-determine-the-clinical-efficacy-of-treatment.html
  

  •  
• 
  4

  (2014) The first edition of a guideline for treating Ebola haemorrhagic fever announcement
  

  •  
• 
  5

  (2014) West Africa rejected the Chinese Medicine China donated
  [accessed 18.10.14]
  http://info.3g.qq.com/g/s?sid=Abc8JvuLxLfkXE7Z5J9TtEuu&aid=td_news_ss&id=news_20141014042152&pos=index5_front&icfa=home_touch&iarea=152
  

  •  
• 
  6

  Minghe Lin, D.Z.
  A clinical trial of Pien Tze Huang treating heat toxin stagnation type of advanced hepatocellular carcinoma
  (2012) Fujian Med, 1, pp. 8-9.
  

  •  
• 
  7

  Zhang, L., Lam, W.P., Lü, L., Wang, C., Wong, Y.W., Lam, L.H., Tang, H.C., (...), Yew, D.T.W.

  Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke
  (2010) Chinese Medicine, 5, art. no. 35. Cited 2 times.
  http://www.cmjournal.org/content/5/1/35
  doi: 10.1186/1749-8546-5-35
  

  • View at Publisher
• 
  8

  Rongxia Wei, D.Z., Erjun, Z., Hongliang, Z.
  Pien Tze Huang treat patient with advanced esophagus cancer
  (2011) Heibei Med, 17, p. 2681.
  

  •  
• 
  9

  Ye, D.
  Pien Tze Huang treat 23 cases of mumps meningoencephalitis
  (1999) Fujian Med, 6, pp. 128-129.
  

  •  
• 
  10

  Zhao, S.
  (2008) A clinical trial on Pien Tze Huang capsule with interventional chemotherapy treating patients with primary liver cancer. Beijing Pharmaceutical Science and Technology Development Association Conference. Beijing, China: National Heavy Liver and Blood Purification Artificial Liver Research Collaborative Group, the Chinese Medical Association Continuing Education Department, China Foundation for Hepa
  

  •  
• 
  11

  Kobayashi, Y., Hasegawa, T., Sato, M., Suzuki, E., Arakawa, M.

  Pneumonia due to the Chinese medicine Pien Tze Huang
  (1996) Japanese Journal of Thoracic Diseases, 34 (7), pp. 810-815.
  
• 
  12

  Lin, Y.-C., Chen, Y.-C., Chen, T.-H., Chen, H.-H., Tsai, W.-J.

  Acute Kidney Injury Associated with Hepato-protective Chinese Herb - Pien Tze Huang
  (2011) Journal of Experimental and Clinical Medicine, 3 (4), pp. 184-186. Cited 2 times.
  doi: 10.1016/j.jecm.2011.07.005
  

  • View at Publisher
• 
  13

  Hong Kong
  

  •  
• 
  14

  (2014) West Africa rejected the Chinese Medicine China donated
  

  •  
• 
  15

  Andrews, J.C., Schünemann, H.J., Oxman, A.D., Pottie, K., Meerpohl, J.J., Coello, P.A., Rind, D., (...), Guyatt, G.

  GRADE guidelines: 15. Going from evidence to recommendation - Determinants of a recommendation's direction and strength
  (2013) Journal of Clinical Epidemiology, 66 (7), pp. 726-735. Cited 104 times.
  doi: 10.1016/j.jclinepi.2013.02.003
  

  • View at Publisher

  Zhang, Y.; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street, Canada
© Copyright 2016 Elsevier B.V., All rights reserved.